Vasodilation Elicited by Isoxsuprine, Identified by High-Throughput Virtual Screening of Compound Libraries, Involves Activation of the NO/cGMP and H₂S/K


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 Mar 2019
Historique:
received: 05 02 2019
revised: 05 03 2019
accepted: 08 03 2019
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 22 6 2019
Statut: epublish

Résumé

Recently, our research group demonstrated that uvaol and ursolic acid increase NO and H₂S production in aortic tissue. Molecular docking studies showed that both compounds bind with high affinity to endothelial NO synthase (eNOS) and cystathionine gamma-lyase (CSE). The aim of this study was to identify hits with high binding affinity for the triterpene binding-allosteric sites of eNOS and CSE and to evaluate their vasodilator effect. Additionally, the mechanism of action of the most potent compound was explored. A high-throughput virtual screening (HTVS) of 107,373 compounds, obtained from four ZINC database libraries, was performed employing the crystallographic structures of eNOS and CSE. Among the nine top-scoring ligands, isoxsuprine showed the most potent vasodilator effect. Pharmacological evaluation, employing the rat aorta model, indicated that the vasodilation produced by this compound involved activation of the NO/cGMP and H₂S/K

Identifiants

pubmed: 30862086
pii: molecules24050987
doi: 10.3390/molecules24050987
pmc: PMC6429095
pii:
doi:

Substances chimiques

Adrenergic alpha-1 Receptor Antagonists 0
Calcium Channel Blockers 0
Small Molecule Libraries 0
Vasodilator Agents 0
Nitric Oxide 31C4KY9ESH
Adenosine Triphosphate 8L70Q75FXE
Cyclic GMP H2D2X058MU
Isoxsuprine R15UI3245N
Hydrogen Sulfide YY9FVM7NSN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Struct Biol. 1999 Mar;6(3):233-42
pubmed: 10074942
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Equine Vet J. 2000 Mar;32(2):119-24
pubmed: 10743967
Circulation. 2000 Aug 8;102(6):677-84
pubmed: 10931809
Bull Exp Biol Med. 2000 Aug;130(8):763-5
pubmed: 11177237
EMBO J. 2001 Nov 1;20(21):6008-16
pubmed: 11689441
Can J Physiol Pharmacol. 2002 Mar;80(3):218-25
pubmed: 11991233
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
Comb Chem High Throughput Screen. 2004 Jun;7(4):259-69
pubmed: 15200375
J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
pubmed: 15667143
Curr Vasc Pharmacol. 2005 Apr;3(2):147-58
pubmed: 15853634
Circulation. 2005 Aug 23;112(8):1198-205
pubmed: 16116070
Kathmandu Univ Med J (KUMJ). 2003 Apr-Jun;1(2):85-90
pubmed: 16388203
J Mol Graph Model. 2006 Oct;25(2):247-60
pubmed: 16458552
Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):448-55
pubmed: 16700877
J Chem Inf Model. 2006 May-Jun;46(3):1107-23
pubmed: 16711731
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Heart. 2007 Feb;93(2):247-8
pubmed: 17228074
Comp Biochem Physiol C Toxicol Pharmacol. 2007 Nov;146(4):511-8
pubmed: 17644443
J Biol Chem. 2009 Jan 30;284(5):3076-85
pubmed: 19019829
Br J Pharmacol. 2009 Feb;156(4):601-8
pubmed: 19210511
RNA. 2009 Jun;15(6):1219-30
pubmed: 19369428
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H134-43
pubmed: 19429833
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Arzneimittelforschung. 2009;59(9):455-60
pubmed: 19856793
Bioorg Med Chem. 2010 Jan 15;18(2):728-36
pubmed: 20036561
Br J Pharmacol. 2011 Oct;164(3):839-52
pubmed: 21133895
Comb Chem High Throughput Screen. 2011 Jul;14(6):475-87
pubmed: 21521151
J Chem Inf Model. 2011 Jun 27;51(6):1307-14
pubmed: 21604800
J Clin Hypertens (Greenwich). 2011 Sep;13(9):687-9
pubmed: 21896151
Antioxid Redox Signal. 2012 Jul 1;17(1):95-105
pubmed: 22074224
Eur J Nutr. 2013 Feb;52(1):263-72
pubmed: 22322926
Chem Soc Rev. 2012 May 21;41(10):3753-8
pubmed: 22362308
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9161-6
pubmed: 22570497
J Chem Inf Model. 2012 Jul 23;52(7):1757-68
pubmed: 22587354
Fitoterapia. 2012 Sep;83(6):1023-9
pubmed: 22659049
BMC Res Notes. 2012 Jul 23;5:367
pubmed: 22824207
Curr Opin Pharmacol. 2013 Apr;13(2):265-73
pubmed: 23294896
Vascul Pharmacol. 2013 Apr;58(4):307-12
pubmed: 23295260
J Chem Inf Model. 2013 Feb 25;53(2):384-90
pubmed: 23351099
J Pharmacol Exp Ther. 1990 May;253(2):518-24
pubmed: 2338646
Mol Med Rep. 2013 Apr;7(4):1155-8
pubmed: 23426852
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
IUBMB Life. 2013 Aug;65(8):710-5
pubmed: 23847022
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
PLoS One. 2014 May 07;9(5):e96761
pubmed: 24804769
J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):501-15
pubmed: 24872348
Neurochem Res. 2014 Sep;39(9):1733-40
pubmed: 24952068
Drug Discov Today. 2014 Oct;19(10):1595-600
pubmed: 25107670
Nucleic Acids Res. 2015 Jan;43(Database issue):D345-56
pubmed: 25428375
Indian J Pharm Sci. 2015 Jan-Feb;77(1):96-102
pubmed: 25767324
Can J Cardiol. 2015 May;31(5):631-41
pubmed: 25936489
Molecules. 2015 Jul 22;20(7):13384-421
pubmed: 26205061
J Clin Hypertens (Greenwich). 2016 Jan;18(1):10-8
pubmed: 26215211
J Ethnopharmacol. 2015 Sep 15;173:352-60
pubmed: 26239154
Eur J Pharmacol. 2015 Oct 15;765:140-53
pubmed: 26297975
Pharmacol Rep. 2015 Oct;67(5):1041-7
pubmed: 26398401
J Chem Inf Model. 2015 Nov 23;55(11):2324-37
pubmed: 26479676
Acta Physiol (Oxf). 2017 Jan;219(1):108-123
pubmed: 26548576
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Oxid Med Cell Longev. 2016;2016:6904327
pubmed: 26640616
J Hypertens. 2016 Mar;34(3):452-63; discussion 463
pubmed: 26682783
Theriogenology. 2016 Mar 15;85(5):986-998
pubmed: 26739532
J Cardiovasc Pharmacol Ther. 2016 Sep;21(5):478-85
pubmed: 26746429
Am J Physiol Heart Circ Physiol. 2016 Mar 15;310(6):H756-64
pubmed: 26747505
Molecules. 2016 Jan 12;21(1):78
pubmed: 26771591
Biochem Biophys Res Commun. 2016 Feb 19;470(4):961-6
pubmed: 26797282
Clin Exp Hypertens. 2016;38(2):252-9
pubmed: 26825432
J Clin Pharm Ther. 2016 Jun;41(3):260-5
pubmed: 26945564
Int J Mol Med. 2016 Jun;37(6):1558-66
pubmed: 27122056
Int J Hypertens. 2016;2016:1656938
pubmed: 27293880
Oxid Med Cell Longev. 2016;2016:9049782
pubmed: 27413423
Nature. 2016 Sep 1;537(7618):117-121
pubmed: 27556947
Physiol Res. 2016 Oct 24;65(Supplementum 3):S291-S307
pubmed: 27775418
Am J Physiol Cell Physiol. 2017 Jan 1;312(1):C3-C15
pubmed: 27784679
J Chem Inf Model. 2016 Dec 27;56(12):2292-2297
pubmed: 28024397
Int J Mol Sci. 2017 Jan 22;18(1):
pubmed: 28117739
ChemMedChem. 2017 Jun 21;12(12):901-904
pubmed: 28263035
Drug Des Devel Ther. 2017 Aug 04;11:2301-2324
pubmed: 28831242
BMJ. 2017 Dec 22;359:j5542
pubmed: 29273586
Biochem Pharmacol. 2018 Mar;149:42-59
pubmed: 29330066
Int J Mol Sci. 2018 Jan 21;19(1):null
pubmed: 29361737
Transl Neurodegener. 2018 Feb 13;7:3
pubmed: 29456842
Channels (Austin). 2018 Jan 1;12(1):126-136
pubmed: 29577810
Comput Biol Chem. 2018 Jun;74:167-189
pubmed: 29627693
J Auton Pharmacol. 1985 Sep;5(3):213-9
pubmed: 2997229
Life Sci. 1978 Nov 13;23(20):1997-2006
pubmed: 31536
J Pharmacol Exp Ther. 1974 Aug;190(2):243-8
pubmed: 4155764
Biol Reprod. 1984 Jun;30(5):1117-23
pubmed: 6145456
Biochem J. 1982 Aug 15;206(2):267-77
pubmed: 7150244
Protein Eng. 1994 Mar;7(3):385-91
pubmed: 8177887
Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):505-12
pubmed: 8897455
Equine Vet J Suppl. 1995 Sep;(19):101-7
pubmed: 8933076

Auteurs

Daniella Medina-Ruiz (D)

Posgrado en Ciencias Químico Biológicas, Facultad de Química, Universidad Autónoma de Querétaro, Cerro de las Campanas S/N, Querétaro C.P. 76010, Mexico. daniellamedinar@gmail.com.
Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. daniellamedinar@gmail.com.

Berenice Erreguin-Luna (B)

Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. bereel@outlook.com.

Francisco J Luna-Vázquez (FJ)

Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. fjlunavz@yahoo.com.mx.

Antonio Romo-Mancillas (A)

Laboratorio de Diseño Asistido por Computadora y Síntesis de Fármacos, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. ruben.romo@uaq.mx.

Alejandra Rojas-Molina (A)

Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. rojasa@uaq.mx.

César Ibarra-Alvarado (C)

Laboratorio de Investigación Química y Farmacológica de Productos Naturales, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico. cibarra@uaq.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH